These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2170647)
1. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 1. Structure-activity relationships of the benzophenone nucleus. Gapinski DM; Mallett BE; Froelich LL; Jackson WT J Med Chem; 1990 Oct; 33(10):2798-807. PubMed ID: 2170647 [TBL] [Abstract][Full Text] [Related]
2. Benzophenone dicarboxylic acid antagonists of leukotriene B4. 2. Structure-activity relationships of the lipophilic side chain. Gapinski DM; Mallett BE; Froelich LL; Jackson WT J Med Chem; 1990 Oct; 33(10):2807-13. PubMed ID: 2170648 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists. Jackson WT; Boyd RJ; Froelich LL; Gapinski DM; Mallett BE; Sawyer JS J Med Chem; 1993 Jun; 36(12):1726-34. PubMed ID: 8389876 [TBL] [Abstract][Full Text] [Related]
4. omega-[(4-Phenyl-2-quinolyl)oxy]alkanoic acid derivatives: a new family of potent LTB4 antagonists. Labaudinière R; Hendel W; Terlain B; Cavy F; Marquis O; Dereu N J Med Chem; 1992 Nov; 35(23):4306-14. PubMed ID: 1333011 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the spatial arrangement of the two acid-binding sites on the human neutrophil LTB4 receptor. Chaney MO; Froelich LL; Gapinski DM; Mallett BE; Jackson WT Receptor; 1992; 2(3):169-79. PubMed ID: 1335328 [TBL] [Abstract][Full Text] [Related]
6. Comparison of antagonist and agonist binding to the leukotriene B4 receptor intact human polymorphonuclear neutrophils (PMN). Jackson RH; Morrissey MM; Sills MA; Jarvis MF J Pharmacol Exp Ther; 1992 Jul; 262(1):80-9. PubMed ID: 1320692 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of a series of substituted-phenylpropionic acids as a novel class of leukotriene B4 antagonists. Konno M; Sakuyama S; Nakae T; Hamanaka N; Miyamoto T; Kawasaki A Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():411-4. PubMed ID: 1847779 [No Abstract] [Full Text] [Related]
8. Novel molecules that antagonize leukotriene B4 binding to neutrophils. Lin AH; Morris J; Wishka DG; Gorman RR Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955 [TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones. Herron DK; Goodson T; Bollinger NG; Swanson-Bean D; Wright IG; Staten GS; Thompson AR; Froelich LL; Jackson WT J Med Chem; 1992 May; 35(10):1818-28. PubMed ID: 1316967 [TBL] [Abstract][Full Text] [Related]
10. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist. Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777 [No Abstract] [Full Text] [Related]
12. A novel series of [2-[methyl(2-phenethyl)amino]-2-oxoethyl] benzene-containing leukotriene B4 antagonists: initial structure-activity relationships. Huang FC; Chan WK; Moriarty KJ; Poli G; Morrissette MM; Galemmo RA; Warus JD; Dankulich WP; Sutherland CA J Med Chem; 1996 Sep; 39(19):3748-55. PubMed ID: 8809163 [TBL] [Abstract][Full Text] [Related]
13. 4-[2-[Methyl(2-phenethyl)amino]-2-oxoethyl]-8-(phenylmethoxy)-2- naphthalenecarboxylic acid: a high affinity, competitive, orally active leukotriene B4 receptor antagonist. Huang FC; Chan WK; Warus JD; Morrissette MM; Moriarty KJ; Chang MN; Travis JJ; Mitchell LS; Nuss GW; Sutherland CA J Med Chem; 1992 Oct; 35(22):4253-5. PubMed ID: 1331462 [No Abstract] [Full Text] [Related]
14. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist. Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships study of two series of leukotriene B4 antagonists: novel indolyl and naphthyl compounds substituted with a 2-[methyl(2-phenethyl)amino]-2-oxoethyl side chain. Chan WK; Huang FC; Morrissette MM; Warus JD; Moriarty KJ; Galemmo RA; Dankulich WD; Poli G; Sutherland CA J Med Chem; 1996 Sep; 39(19):3756-68. PubMed ID: 8809164 [TBL] [Abstract][Full Text] [Related]
16. omega-[(4,6-Diphenyl-2-pyridyl)oxy]alkanoic acid derivatives: a new family of potent and orally active LTB4 antagonists. Labaudinière R; Dereu N; Cavy F; Guillet MC; Marquis O; Terlain B J Med Chem; 1992 Nov; 35(23):4315-24. PubMed ID: 1333012 [TBL] [Abstract][Full Text] [Related]
17. Affinity labeling of the membrane protein-binding component of human polymorphonuclear leukocyte receptors for leukotriene B4. Goldman DW; Gifford LA; Young RN; Marotti T; Cheung MK; Goetzl EJ J Immunol; 1991 Apr; 146(8):2671-7. PubMed ID: 1849936 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C blockers and neutrophil receptors for leukotriene B4. O'Flaherty JT; Jacobson D Biochem Biophys Res Commun; 1989 Sep; 163(3):1456-60. PubMed ID: 2551291 [TBL] [Abstract][Full Text] [Related]
19. 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8- propyl-2H-1-benzopyran-2-carboxylic acid: an orally active selective leukotriene B4 receptor antagonist. Djuric SW; Collins PW; Jones PH; Shone RL; Tsai BS; Fretland DJ; Butchko GM; Villani-Price D; Keith RH; Zemaitis JM J Med Chem; 1989 Jun; 32(6):1145-7. PubMed ID: 2542550 [No Abstract] [Full Text] [Related]
20. Detergent solubilization of human neutrophil leukotriene B4 receptors. Lin AH; Ruppel PL; Gorman RR Biochem Biophys Res Commun; 1985 Apr; 128(2):878-83. PubMed ID: 2986628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]